Division of Pulmonary, Critical Care Medicine, Allergy, and Clinical Immunology;The David Geffen School of Medicine at UCLA, Los Angeles, CA.
The Division of Infectious Diseases, Department of Medicine, Stritch School of Medicine, Loyola University Chicago, Maywood, IL.
Expert Opin Pharmacother. 2021 Aug;22(11):1455-1473. doi: 10.1080/14656566.2021.1904891.
: Over the past few decades, antimicrobial resistance (AMR) has skyrocketed globally among bacteria within the Family Enterobacteriaceae (i.e. spp, spp, spp, spp, and others). Enterobacteriaceae are intestinal flora and are important pathogens in nosocomial and community settings. Enterobacteriaceae spread easily between humans and may acquire AMR via plasmids or other mobile resistance elements. The emergence and spread of multidrug resistant (MDR) clones have greatly limited therapeutic options. Some infections are untreatable with existing antimicrobials.: The authors discuss the escalation of CRE globally, the epidemiology and outcomes of CRE infections, the optimal therapy, and the potential role of several new antimicrobials to combat MDR organisms. An exhaustive search for literature related to Enterobacteriaceae was performed using PubMed, using the following key words: antimicrobial resistance; carbapenemases; Enterobacterales; Enterobacteriaceae; ; global epidemiology; metallo-β-lactamases; multidrug resistance; New Delhi Metalloproteinase-1 (NDM-1); plasmids: Innovation and development of new classes of antibacterial agents are critical to expand effective therapeutic options. The authors encourage the judicious use of antibiotics and aggressive infection-control measures are essential to minimize the spread of AMR.
在过去的几十年中,肠杆菌科(即 spp、 spp、 spp、 spp 和其他细菌)中的细菌在全球范围内的抗微生物药物耐药性(AMR)急剧上升。肠杆菌科是肠道菌群,也是医院和社区环境中重要的病原体。肠杆菌科很容易在人与人之间传播,并且可能通过质粒或其他移动耐药元件获得 AMR。多药耐药(MDR)克隆的出现和传播大大限制了治疗选择。一些感染现有的抗菌药物无法治疗。
作者讨论了 CRE 在全球的升级、CRE 感染的流行病学和结果、最佳治疗方法以及几种新抗菌药物对抗 MDR 生物体的潜在作用。使用 PubMed 对与肠杆菌科相关的文献进行了全面搜索,使用了以下关键词:抗微生物药物耐药性;碳青霉烯酶;肠杆菌目;肠杆菌科;全球流行病学;金属β-内酰胺酶;多药耐药;新德里金属蛋白酶-1(NDM-1);质粒。
创新和开发新类别的抗菌药物对于扩大有效的治疗选择至关重要。作者鼓励合理使用抗生素,并采取积极的感染控制措施对于最大限度地减少 AMR 的传播至关重要。